From the Fundraising Front: How Rox Medical Made the Move to Hypertension and Raised $40m
Rox Medical CEO Rodney Brenneman says he’s never had a tougher time raising capital. But the deed is done, and Rox is ready to move forward into the promising hypertension area.
From the Fundraising Front: How Rox Medical Made the Move to Hypertension and Raised $40m
Rox Medical CEO Rodney Brenneman says he’s never had a tougher time raising capital. But the deed is done, and Rox is ready to move forward into the promising hypertension area.